Physcient

Physcient is developing a novel platform technology for surgical dissection, aiming to address a fundamental and largely unchanged aspect of surgery. Its Differential Dissection™ devices use a proprietary method to selectively disrupt loose connective tissue without cutting or burning, which promises to significantly reduce procedure times and improve patient safety by minimizing unintended damage. The company has developed the technology into multiple form factors for open, laparoscopic, endoscopic, and robotic surgery, positioning it as a potential new standard of care across numerous surgical disciplines. Led by a technically deep founding team with experience in robotics and biomechanics, Physcient is a private, likely pre-revenue or early-revenue stage company commercializing its first products.

Differential Dissection™ is a powered blunt dissection platform that uses controlled mechanical forces to selectively disrupt loose connective tissue while sparing critical anatomical structures like blood vessels and nerves. It is inherently tissue-selective, does not cut or burn, and provides self-guidance to help surgeons find and stay in the correct surgical plane.

Physcient's direct competitors are traditional blunt dissection tools (fingers, gauze, clamps) and energy-based dissection devices (electrosurgical and ultrasonic tools). Its value proposition is superiority over manual methods in speed and precision, and safety superiority over energy devices by eliminating thermal spread and inadvertent cutting. It currently has no direct peer offering a purely mechanical, tissue-selective dissection platform.